FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016155151> ?p ?o ?g. }

• W2016155151 endingPage "1110" @default.
• W2016155151 startingPage "1106" @default.
• W2016155151 abstract "Sorafenib is the standard treatment for patients with an advanced stage of hepatocellular carcinoma (HCC). The aims of this study were (i) to evaluate the tolerance and survival of sorafenib-treated patients, in a nonselected population, especially in Child-Pugh B patients; and (ii) to identify potential prognostic factors of survival.From April 2007 to December 2008, 50 patients received sorafenib for advanced HCC. Seventeen (34%) were Child-Pugh B patients. We recorded adverse events and the duration of treatment and survival. For 34 patients with histopathologically proven HCC, immunophenotypical analysis was carried out using antibodies against cluster differentiation 34, vascular endothelial growth factor, phosphorylated ERK, cytokeratin 19, and phosphorylated stat3.Patients with Child-Pugh B cirrhosis had a more advanced stage of the disease compared with Child-Pugh A patients. The occurrence of adverse events was similar in Child-Pugh A and Child-Pugh B patients. Duration of treatment until discontinuation for bad tolerance was lower in Child-Pugh B patients (1.8 vs. 5 months, P=0.02). Survival of Child-Pugh A patients was higher compared with Child-Pugh B patients (8.9 vs. 2 months, P=0.004). Barcelona Clinic Liver Cancer stage, Eastern Cooperative Oncology Group Performance Status, portal vein impairment, extra-hepatic spread, and alpha-foetoprotein were also prognostic factors. In multivariate analysis, the sole factor associated with survival was the Barcelona Clinic Liver Cancer stage. None of the immunohistological markers used was associated with tolerance and survival.Occurrence of adverse events is similar in Child-Pugh A and Child-Pugh B patients. Nevertheless, the survival of Child-Pugh B patients is very low. Whether liver function or tumor spread is responsible for mortality is unclear. Opportunity of treatment for Child-Pugh B patients is questionable. The immunophenotype of tumoral tissue was not predictive of survival." @default.
• W2016155151 created "2016-06-24" @default.
• W2016155151 creator A5023383248 @default.
• W2016155151 creator A5031172542 @default.
• W2016155151 creator A5041848580 @default.
• W2016155151 creator A5045521060 @default.
• W2016155151 creator A5048710140 @default.
• W2016155151 creator A5063437154 @default.
• W2016155151 creator A5063967586 @default.
• W2016155151 creator A5070237613 @default.
• W2016155151 creator A5084110348 @default.
• W2016155151 date "2010-09-01" @default.
• W2016155151 modified "2023-09-25" @default.
• W2016155151 title "Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib" @default.
• W2016155151 cites W1971837077 @default.
• W2016155151 cites W1975154077 @default.
• W2016155151 cites W1986209953 @default.
• W2016155151 cites W1994193851 @default.
• W2016155151 cites W2009671859 @default.
• W2016155151 cites W2020215421 @default.
• W2016155151 cites W2022169488 @default.
• W2016155151 cites W2049988916 @default.
• W2016155151 cites W2063232040 @default.
• W2016155151 cites W2067117806 @default.
• W2016155151 cites W2100070712 @default.
• W2016155151 cites W2114029473 @default.
• W2016155151 cites W2123140856 @default.
• W2016155151 cites W2127248987 @default.
• W2016155151 cites W2137052325 @default.
• W2016155151 cites W2139248078 @default.
• W2016155151 cites W2157769714 @default.
• W2016155151 doi "https://doi.org/10.1097/meg.0b013e3283386053" @default.
• W2016155151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20300004" @default.
• W2016155151 hasPublicationYear "2010" @default.
• W2016155151 type Work @default.
• W2016155151 sameAs 2016155151 @default.
• W2016155151 citedByCount "67" @default.
• W2016155151 countsByYear W20161551512012 @default.
• W2016155151 countsByYear W20161551512013 @default.
• W2016155151 countsByYear W20161551512014 @default.
• W2016155151 countsByYear W20161551512015 @default.
• W2016155151 countsByYear W20161551512016 @default.
• W2016155151 countsByYear W20161551512017 @default.
• W2016155151 countsByYear W20161551512018 @default.
• W2016155151 countsByYear W20161551512019 @default.
• W2016155151 countsByYear W20161551512020 @default.
• W2016155151 countsByYear W20161551512023 @default.
• W2016155151 crossrefType "journal-article" @default.
• W2016155151 hasAuthorship W2016155151A5023383248 @default.
• W2016155151 hasAuthorship W2016155151A5031172542 @default.
• W2016155151 hasAuthorship W2016155151A5041848580 @default.
• W2016155151 hasAuthorship W2016155151A5045521060 @default.
• W2016155151 hasAuthorship W2016155151A5048710140 @default.
• W2016155151 hasAuthorship W2016155151A5063437154 @default.
• W2016155151 hasAuthorship W2016155151A5063967586 @default.
• W2016155151 hasAuthorship W2016155151A5070237613 @default.
• W2016155151 hasAuthorship W2016155151A5084110348 @default.
• W2016155151 hasConcept C126322002 @default.
• W2016155151 hasConcept C143998085 @default.
• W2016155151 hasConcept C146357865 @default.
• W2016155151 hasConcept C151730666 @default.
• W2016155151 hasConcept C197934379 @default.
• W2016155151 hasConcept C2776231280 @default.
• W2016155151 hasConcept C2777214474 @default.
• W2016155151 hasConcept C2777546739 @default.
• W2016155151 hasConcept C2778019345 @default.
• W2016155151 hasConcept C2778695046 @default.
• W2016155151 hasConcept C2778715236 @default.
• W2016155151 hasConcept C41260117 @default.
• W2016155151 hasConcept C71924100 @default.
• W2016155151 hasConcept C86803240 @default.
• W2016155151 hasConcept C90924648 @default.
• W2016155151 hasConceptScore W2016155151C126322002 @default.
• W2016155151 hasConceptScore W2016155151C143998085 @default.
• W2016155151 hasConceptScore W2016155151C146357865 @default.
• W2016155151 hasConceptScore W2016155151C151730666 @default.
• W2016155151 hasConceptScore W2016155151C197934379 @default.
• W2016155151 hasConceptScore W2016155151C2776231280 @default.
• W2016155151 hasConceptScore W2016155151C2777214474 @default.
• W2016155151 hasConceptScore W2016155151C2777546739 @default.
• W2016155151 hasConceptScore W2016155151C2778019345 @default.
• W2016155151 hasConceptScore W2016155151C2778695046 @default.
• W2016155151 hasConceptScore W2016155151C2778715236 @default.
• W2016155151 hasConceptScore W2016155151C41260117 @default.
• W2016155151 hasConceptScore W2016155151C71924100 @default.
• W2016155151 hasConceptScore W2016155151C86803240 @default.
• W2016155151 hasConceptScore W2016155151C90924648 @default.
• W2016155151 hasIssue "9" @default.
• W2016155151 hasLocation W20161551511 @default.
• W2016155151 hasLocation W20161551512 @default.
• W2016155151 hasOpenAccess W2016155151 @default.
• W2016155151 hasPrimaryLocation W20161551511 @default.
• W2016155151 hasRelatedWork W1879835999 @default.
• W2016155151 hasRelatedWork W2008626862 @default.
• W2016155151 hasRelatedWork W2021965961 @default.
• W2016155151 hasRelatedWork W2036867087 @default.
• W2016155151 hasRelatedWork W2047608762 @default.
• W2016155151 hasRelatedWork W2062847965 @default.

• next